Canopy Growth Downgraded To Neutral From Overweight At Piper Sandler

green-leafed plant closeup photography

Source: Unsplash 

Piper Sandler analyst Michael Lavery downgraded Canopy Growth (CGC) to Neutral from Overweight with an unchanged price target of $27.

Canopy shares are up 215% since October, likely driven by improving sentiment around cannabis and potential for U.S. legalization following the elections, Lavery tells investors in a research note.

The company currently trades at 21 times estimated 2022 sales, says the analyst, who does not see further upside to valuation based on fundamentals. Federal legalization of marijuana in the U.S. could still be two years away, Lavery adds.

Disclaimer: TheFly's news is intended for informational purposes only and does not claim to be actionable for investment decisions. Read more at  more

How did you like this article? Let us know so we can better customize your reading experience.


Leave a comment to automatically be entered into our contest to win a free Echo Show.